Teva buys Anda for $500 million - ISRAEL21c
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Performance Analysis - Simply Wall St
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharma shares up after positive results from migraine drug trial: Tirrell
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Pharmaceutical Q1 results in focus with eye on revenue numbers | Seeking Alpha
Teva Pharmaceutical Q1 results in focus with eye on revenue numbers | Seeking Alpha
Can Teva Pharmaceutical's Q4 results bring positive surprise? | Seeking Alpha
Subcutaneous Cinqair results add to Teva's troubles
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Questions that global generic behemoth Teva's results raise for Indian pharma - BusinessToday
Teva Pharmaceutical loses another CEO, leaving investors to guess what's next | Mint
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Articles about Teva Pharmaceuticals
